ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2135

miRNA-223 Delivery to Synovial Fibroblasts Via Monocyte-Derived Extracellular Vesicles Promotes Their Proliferation

Florian M.P. Meier1, Derek S. Gilchrist1, Derek Baxter2, Diane Vaughan1, Margaret Mullin3, David W. McCarey4, Pawel Herzyk5, Julie Galbraith5, Donna McIntyre1, Russka Shumnalieva6, Ulf Müller-Ladner7, Iain B. McInnes8 and Mariola Kurowska-Stolarska1, 1Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom, 2Department of Rheumatology, University Hospital Ayr, Ayr, United Kingdom, 3School of Life Sciences, University of Glasgow, Glasgow, United Kingdom, 4Glasgow Royal Infirmary, Glasgow, United Kingdom, 5Polyomics Facility, Institute of Molecular Cell and Systems Biology, University of Glasgow, Glasgow, United Kingdom, 6Department of Internal Medicine, Clinic of Rheumatology, Sofia, Bulgaria, 7Internal Medicine and Rheumatology, Justus-Liebig-University of Giessen, Kerckhoff-Klinik, Bad Nauheim, Germany, 8Institute of Infection, Immunity and Inflammation, College of Medicine, Veterinary Medicine and Life Sciences, University of Glasgow, Glasgow, United Kingdom

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Fibroblasts, Macrophage, microparticles and monocytes, MicroRNA

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis II

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Recently, it was shown that extracellular vesicles (EV) convey microRNAs (miR) from platelets to endothelial cells1and regulate recipient cell gene expression. Interaction of synovial monocyte (MC)/macrophages with synovial fibroblasts (SF) is a key step to the inflammatory process in rheumatoid arthritis (RA). We hypothesised that MC/macrophage regulate SF behavior by delivering specific microRNA via EVs.

Methods: Characterization of EVs from human CD14+MCs and THP-1 cells was performed using scanning electron microscopy (SEM, n=3), nanosight trafficking analysis (NTA, n=3-7); and flow cytometry (n>4) with predefined sized beads for gating. smallRNA sequencing was performed on macrophages (n=4) and RASFs (n=4) as well as on macrophage-derived EVs (n=4). Macrophages were differentiated by culturing peripheral blood (PB) CD14+MCs from RA patients with M-CSF and either stimulated with LPS or not. In addition, matched RA PB and synovial fluid CD14+ (n=8), PB CD14+ from RA DMARD responders (n=16), DMARD non-responders (n=22), Biologic resistant (n=41), and age-matched healthy controls (n=21) were isolated and used for validation. (Pre-)miR-223 expression and copy number was quantified in cells or tissues via TLDA, qPCR & in situ hybridisation with specific primers and probes. Targeted pathways were identified using prediction algorithms (TargetScanHuman6.2). Transfer of miR-223 from MCs to SFs was determined by fluorescence microscopy, direct cell co-culture and FACS, as well as transwell co-culture. RASF Proliferation assays and IL-6 ELISAs served as read-out.

Results: SEM & NTA revealed a mean size of EVs from MCs & THP-1 cells of about 250nm (range 50-800nm). EV production was induced in myeloid cells by LPS (p<0.05). SmallRNA sequencing revealed high levels of miR-223 in macrophages as opposed to a lack of its expression in RASF. miR-223 levels were significantly higher in PB CD14+ cells of DMARD responders compared to DMARD non-responders and Biologic resistant RA patients (p<0.05 and p<0.01). miR-223 levels in CD14+ cells showed significant positive correlations to CDAI and SDAI. miR-223 was downregulated in synovial fluid MCs compared to matched PB controls (p< 0.01) and its expression was down-regulated in MCs/macrophages upon LPS stimulation. In contrast, EVs derived from LPS stimulated THP-1 cells contained higher levels of miR-223 suggesting stimulation driven packing of miR-223 into EVs. If co-cultured with MCs for 3d, RASF acquire miR-223 expression, but not pre-miR-223 to a significant extent (n=6, Ctvalues <30) confirming transfer of mature miR-223 between cells. Prediction algorithms identified FBXW7, a ubiquitin ligase targeting cyclin E, as a candidate target for miR-223 in RASF. Co-culture of RASF with THP-1-derived EV increased RASF proliferation (n=3, p<0.05). miR-223 transfection (25nM & 50nM) itself led to an increase of RASF proliferation after 72 and 96h (n=6-8, p<0.01 for all).

Conclusion: miR-223 transfer from MCs/macrophages to SFs by EVs during initial or chronic phases of synovial inflammation could promote SF proliferation and represent a novel intercellular mechanism underlying the pathogenesis of rheumatoid arthritis.

1Laffont, B. et al. Blood (2013)


Disclosure: F. M. P. Meier, None; D. S. Gilchrist, None; D. Baxter, Roche Pharmaceuticals, 2; D. Vaughan, None; M. Mullin, None; D. W. McCarey, Roche Pharmaceuticals, 5; P. Herzyk, None; J. Galbraith, None; D. McIntyre, None; R. Shumnalieva, None; U. Müller-Ladner, Roche Pharmaceuticals, 5; I. B. McInnes, Roche Pharmaceuticals, 2; M. Kurowska-Stolarska, Roche Pharmaceuticals, 2.

To cite this abstract in AMA style:

Meier FMP, Gilchrist DS, Baxter D, Vaughan D, Mullin M, McCarey DW, Herzyk P, Galbraith J, McIntyre D, Shumnalieva R, Müller-Ladner U, McInnes IB, Kurowska-Stolarska M. miRNA-223 Delivery to Synovial Fibroblasts Via Monocyte-Derived Extracellular Vesicles Promotes Their Proliferation [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/mirna-223-delivery-to-synovial-fibroblasts-via-monocyte-derived-extracellular-vesicles-promotes-their-proliferation/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mirna-223-delivery-to-synovial-fibroblasts-via-monocyte-derived-extracellular-vesicles-promotes-their-proliferation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology